Mapping health assessment questionnaire disability index (HAQ-DI) score, pain visual analog scale (VAS), and disease activity score in 28 joints (DAS28) onto the EuroQol-5D (EQ-5D) utility score with the KORean Observational study Network for Arthritis (KORONA) registry data

[1]  S. Davis,et al.  Mapping from the Health Assessment Questionnaire to the EQ-5D: the impact of different algorithms on cost-effectiveness results. , 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[2]  Allan Wailoo,et al.  A Comparison of Direct and Indirect Methods for the Estimation of Health Utilities from Clinical Outcomes , 2014, Medical decision making : an international journal of the Society for Medical Decision Making.

[3]  S. Bang,et al.  Prediction for TNF Inhibitor Users in RA Patients According to Reimbursement Criteria Based on DAS28 , 2014 .

[4]  M. Wong,et al.  Improving the mapping of condition-specific health-related quality of life onto SF-6D score , 2014, Quality of Life Research.

[5]  J. Brazier,et al.  Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey. , 2014, Health technology assessment.

[6]  M. Lai,et al.  Disease activity affects all domains of quality of life in patients with rheumatoid arthritis and is modified by disease duration. , 2014, Clinical and experimental rheumatology.

[7]  H. A. Park,et al.  The Korea National Health and Nutrition Examination Survey as a Primary Data Source , 2013, Korean journal of family medicine.

[8]  Allan Wailoo,et al.  The relationship between EQ-5D, HAQ and pain in patients with rheumatoid arthritis , 2013, Rheumatology.

[9]  Donna Rowen,et al.  Mapping to obtain EQ-5D utility values for use in NICE health technology assessments. , 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[10]  S. Bae,et al.  Prevalence and incidence of rheumatoid arthritis in South Korea , 2013, Rheumatology International.

[11]  J. Yfantopoulos,et al.  Longitudinal predictive ability of mapping models: examining post-intervention EQ-5D utilities derived from baseline MHAQ data in rheumatoid arthritis patients , 2013, The European Journal of Health Economics.

[12]  Jin-Hee Ahn,et al.  Mapping EORTC QLQ-C30 onto EQ-5D for the assessment of cancer patients , 2012, Health and Quality of Life Outcomes.

[13]  S. Bang,et al.  Korean Observational Study Network for Arthritis (KORONA): establishment of a prospective multicenter cohort for rheumatoid arthritis in South Korea. , 2012, Seminars in arthritis and rheumatism.

[14]  Helen Dakin,et al.  Mapping analyses to estimate EQ-5D utilities and responses based on Oxford Knee Score , 2012, Quality of Life Research.

[15]  Roberta Ara,et al.  Tails from the peak district: adjusted limited dependent variable mixture models of EQ-5D questionnaire health state utility values. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[16]  Jinoos Yazdany,et al.  Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice , 2012, Arthritis care & research.

[17]  N. Wintfeld,et al.  Economic evaluation of tocilizumab combination in the treatment of moderate-to-severe rheumatoid arthritis in Italy , 2012, Journal of medical economics.

[18]  M. Barry,et al.  Understanding the Relationship between the EQ-5D, SF-6D, HAQ and Disease Activity in Inflammatory Arthritis , 2012, PharmacoEconomics.

[19]  C. Bombardier,et al.  Comparison of anti-TNF treatment initiation in rheumatoid arthritis databases demonstrates wide country variability in patient parameters at initiation of anti-TNF therapy. , 2011, Seminars in arthritis and rheumatism.

[20]  Nicky J Welton,et al.  NICE DSU Technical Support Document 18 , 2011 .

[21]  X. Badia,et al.  Using HAQ-DI to estimate HUI-3 and EQ-5D utility values for patients with rheumatoid arthritis in Spain. , 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[22]  S. Bae,et al.  Factors influencing quality of life (QOL) for Korean patients with rheumatoid arthritis (RA) , 2011, Rheumatology International.

[23]  Scale Characteristics and Mapping Accuracy of the US EQ-5D, UK EQ-5D, and SF-6D in Patients with Rheumatoid Arthritis , 2010, The Journal of Rheumatology.

[24]  Martin J Buxton,et al.  Mapping of the EQ-5D index from clinical outcome measures and demographic variables in patients with coronary heart disease , 2010, Health and quality of life outcomes.

[25]  L. Sharples,et al.  ResearchMapping of the EQ-5 D index from clinical outcome measures and demographic variables in patients with coronary heart disease , 2010 .

[26]  Aki Tsuchiya,et al.  A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures , 2010, The European Journal of Health Economics.

[27]  D. Street,et al.  International comparisons in valuing EQ-5D health states: a review and analysis. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[28]  Kent H. Summers,et al.  Predicting EQ-5D utility scores from the 25-item National Eye Institute Vision Function Questionnaire (NEI-VFQ 25) in patients with age-related macular degeneration , 2009, Quality of Life Research.

[29]  P Tugwell,et al.  Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. , 2008, Arthritis and rheumatism.

[30]  L. Carmona,et al.  Are the C-reactive protein values and erythrocyte sedimentation rate equivalent when estimating the 28-joint disease activity score in rheumatoid arthritis? , 2008, Clinical and experimental rheumatology.

[31]  Albert W Wu,et al.  Addressing ceiling effects in health status measures: a comparison of techniques applied to measures for people with HIV disease. , 2007, Health services research.

[32]  P Barton,et al.  A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness. , 2006, Health technology assessment.

[33]  M. Nagashima,et al.  Modeling and cost-effectiveness analysis of etanercept in adults with rheumatoid arthritis in Japan: a preliminary analysis , 2006, Modern rheumatology.

[34]  M. Gold,et al.  Relationship Among Sociodemographic Factors, Clinical Conditions, and Health-related Quality of Life: Examining the EQ-5D in the U.S. General Population , 2005, Quality of Life Research.

[35]  A. Brennan,et al.  Cost effectiveness of adalimumab in the treatment of patients with moderate to severe rheumatoid arthritis in Sweden , 2004, Annals of the rheumatic diseases.

[36]  S. Bae,et al.  Cross-cultural adaptation and validation of the Korean version of the EQ-5D in patients with rheumatic diseases , 2005, Quality of Life Research.

[37]  E. Wagenmakers,et al.  AIC model selection using Akaike weights , 2004, Psychonomic bulletin & review.

[38]  A. Brennan,et al.  Modelling the cost-effectiveness of etanercept in adults with rheumatoid arthritis in the UK. , 2004, Rheumatology.

[39]  G. Stucki,et al.  Rheumatoid arthritis measures: Disease activity score (DAS), disease activity score-28 (DAS28), rapid assessment of disease activity in rheumatology (RADAR), and rheumatoid arthritis disease activity index (RADAI) , 2003 .

[40]  Praveen K. Kopalle,et al.  The impact of collinearity on regression analysis: the asymmetric effect of negative and positive correlations , 2002 .

[41]  J. Brazier,et al.  The estimation of a preference-based measure of health from the SF-36. , 2002, Journal of health economics.

[42]  M. Boyle,et al.  Multiattribute and Single‐Attribute Utility Functions for the Health Utilities Index Mark 3 System , 2002, Medical care.

[43]  E. Cook,et al.  Psychometric evaluation of a Korean Health Assessment Questionnaire for clinical research. , 1998, The Journal of rheumatology.

[44]  David R. Anderson,et al.  Model Selection and Multimodel Inference , 2003 .

[45]  M. Prevoo,et al.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. , 1995, Arthritis and rheumatism.

[46]  F. Arnett.  Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.

[47]  A. Williams.  EuroQol : a new facility for the measurement of health-related quality of life , 1990 .

[48]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[49]  H. Holman,et al.  Measurement of patient outcome in arthritis. , 1980, Arthritis and rheumatism.